Form 4 for ELV Elevance Health
Accepted 2022-02-08 00:00:00 ET · period of report 2022-02-07 · accession 0001156039-22-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-08 | 2022-02-07 | ELV | Penczek Ronald W | CAO, Ctrl | M - OptEx | $258.50 | +2,763 | 2,830 | +4,124% | +$714.2K |
| D | 2022-02-08 | 2022-02-07 | ELV | Penczek Ronald W | CAO, Ctrl | S - Sale+OE | $453.48 | -2,763 | 2,012 | -58% | -$1.25M |
| DM | 2022-02-08 | 2022-02-07 | ELV | Penczek Ronald W | CAO, Ctrl | M - OptEx | $0.00 | -2,763 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-07 | M | A | 357 | $166.97 | 4,122 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-07 | S | D | 2,763 | $453.48 | 2,012 | D | — | — | (F1) Balance includes 3.4072 shares acquired on December 21, 2021 through a dividend reinvestment plan. |
| 3 | Common | Common Stock | 2022-02-07 | M | A | 653 | $271.27 | 4,775 | D | — | — | |
| 4 | Common | Common Stock | 2022-02-07 | M | A | 935 | $307.68 | 3,765 | D | — | — | |
| 5 | Common | Common Stock | 2022-02-07 | M | A | 818 | $232.04 | 2,830 | D | — | — | |
| 6 | Derivative | Employee Stock Option (Right to Buy) | 2022-02-07 | M | D | 935 | $0.00 | 468 | D | $307.68 · — to 2029-03-01 | 935 Common Stock | (F3) The option represents a right to purchase a total of 1,403 shares, and is exercisable in three annual installments, with one installment of 467 shares and two installments of 468 shares each, beginning on 3/1/2020, which is the one-year anniversary of the option grant date. |
| 7 | Derivative | Employee Stock Option (Right to Buy) | 2022-02-07 | M | D | 653 | $0.00 | 1,307 | D | $271.27 · — to 2030-03-02 | 653 Common Stock | (F5) The option represents a right to purchase a total of 1,960 shares, and is exercisable in three annual installments, with two installments of 653 shares each and one installment of 654 shares, beginning on 3/2/2021, which is the one-year anniversary of the option grant date. |
| 8 | Derivative | Employee Stock Option (Right to Buy) | 2022-02-07 | M | D | 818 | $0.00 | 0 | D | $232.04 · — to 2028-03-01 | 818 Common Stock | (F2) The option represents a right to purchase a total of 1,634 shares, and is exercisable in six semi-annual installments, with four installments of 272 shares each and two installments of 273 shares each, beginning on September 1, 2018, which is the six-month anniversary of the option grant date. |
| 9 | Derivative | Employee Stock Option (Right to Buy) | 2022-02-07 | M | D | 357 | $0.00 | 0 | D | $166.97 · — to 2027-03-01 | 357 Common Stock | (F4) The option represents a right to purchase a total of 2,141 shares, and is exercisable in six semi-annual installments, with one installment of 356 shares and five installments of 357 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date. |